Physician
Family Medicine
David Dobratz works in the field of Family Medicine. He attended University of Kansas School of Medicine. He received 1 awards: "CMS Meaningful Use Stage 1 Certification". David Dobratz is a published doctor as well. He has 1 publication published. The latest was: Cyclooxygenase-2 inhibition by rofecoxib reverses naturally occurring fever in humans. David Dobratz accepts Medicare payments and is registered with Medicare.gov.
Publications
Schools
University of Kansas School of Medicine
Procedures Preformed
- Endometrial Biopsy
- Joint Injection
- Mole Removal
- Wart Removal
Doctors Specialties
Accepted Insurances
- HealthKeepers Plus POS
- Beech Street (Multiplan)
- Blue Access
- Blue Advantage HMO
- Blue Care HMO
- Preferred Care Blue PPO
- Great West Healthcare-Cigna
- Advantra HMO
- First Health (Coventry Health Care) EPO
- Freedom Network PPO
- SmartCare PPO
- Medicare Replacement MCR
- Medicare MCR
- MultiPlan
- Preferred Health Network
- Preferred Healthcare PPO
- Private HealthCare Systems
- Savility POS
- TriCare for Life
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Kansas School of Medicine
Drug Facts
NPI NUMBER |
|
1245226166 |
NPPES Provider LastName |
|
DOBRATZ |
NPPES Provider FirstName |
|
DAVID |
NPPES Provider ZIPCode |
|
662102761 |
NPPES Provider State |
|
KS |
Specialty Description |
|
Family Practice |
Total Claim Count |
|
4478.0 |
Distinct Opioid Count |
|
10.0 |
Opioid Claim Count |
|
305.0 |
Percent Opioid Claims |
|
6.81 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
National Provider Identifier [NPI] |
1245226166 |
Last Name Of The Provider |
DOBRATZ |
First Name Of The Provider |
DAVID |
View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog